• Home
  • Store
    • Newsletter Subscriptions
    • Multimedia
    • Books
    • eBooks
    • ABPN SA Courses
    • Social Work Courses
  • CME Center
  • Multimedia
    • Podcast
    • Webinars
    • Blog
    • Psychiatry News Videos
    • Medication Guide Videos
  • Newsletters
    • General Psychiatry
    • Child Psychiatry
    • Addiction Treatment
    • Hospital Psychiatry
    • Geriatric Psychiatry
    • Psychotherapy and Social Work
  • FAQs
  • Med Fact Book Apps
  • Log In
  • Register
  • Welcome
  • Sign Out
  • Subscribe
Home » Topics » Expert Q&A

Expert Q&A
Expert Q&A RSS Feed RSS

Expert Q&A

Diagnosis and Treatment of Gambling Addiction

February 1, 2024
Timothy Fong, MD.
From The Carlat Addiction Treatment Report
Issue Links: Editorial Information | PDF of Issue

QA1_Timothy Fong headshot.pngTimothy Fong, MD. 

Clinical Professor of Psychiatry and Biobehavioral Sciences; Co-Director, Gambling Studies Program; David Geffen School of Medicine at UCLA, Los Angeles, CA.

Dr. Fong receives research support from Connections in Recovery. Relevant financial relationships listed for the author have been mitigated.

Gambling disorder is much more prevalent than many providers realize, and it is a condition that is rarely screened for, let alone treated, by mental health professionals. Here, Dr. Fong reviews the topic, walks us through how to take a good gambling history, make a diagnosis, and how to provide the best treatment.


Read More
Gitlin_image.png
Expert Q&A

Lithium, Antidepressants, and Bipolar Disorder

February 1, 2024
Michael J. Gitlin, M.D.
From The Carlat Psychiatry Report
Issue Links: Editorial Information | PDF of Issue

TCPR_QA_Gitlin headshot.jpgMichael J. Gitlin, MD.

Professor of Clinical Psychiatry and Director of the Mood Disorders Clinic at the David Geffen School of Medicine at UCLA; coauthor of The Essential Guide to Lithium Treatment (Springer, 2016).

Dr. Gitlin has no financial relationships with companies related to this material.

Practical updates on lithium, antipsychotics, and antidepressants in bipolar disorder.


Read More
Expert Q&A

Alcohol Withdrawal: What to Watch For on the Psychiatric Inpatient Unit

January 31, 2024
Caridad Ponce Martinez, MD, FAPA, FASAM
From The Carlat Hospital Psychiatry Report
Issue Links: Editorial Information | PDF of Issue

QA2_Caridad Ponce Martinez_photo.jpgCaridad Ponce Martinez, MD, FAPA, FASAM.

Assistant professor of psychiatry, UMass Chan Medical School, Worcester, MA.

Dr. Ponce Martinez has no financial relationships with companies related to this material.

Dr. Ponce Martinez highlights the need to identify and manage alcohol withdrawal in psychiatric settings, underscoring the use of the CIWA-Ar scale for monitoring symptom progression. While benzodiazepines remain the primary treatment, she reviews alternative treatment strategies and tells us which patients are so high risk that they must be transferred to a medical unit for care.


Read More
Expert Q&A

Substance-Induced Psychosis: Diagnostic Dilemmas and Treatment Options

January 31, 2024
Nicholas Athanasiou, MD, MBA, DFASAM
From The Carlat Hospital Psychiatry Report
Issue Links: Editorial Information | PDF of Issue

QA1_Nicholas Athanasiou_photo.JPGNicholas Athanasiou, MD, MBA, DFASAM.

Associate clinical professor, Psychiatry and Biobehavioral Sciences (DGSOM), UCLA Olive View Psychiatry Residency Program; Supervising Mental Health Psychiatrist, Los Angeles County Department of Mental Health, Los Angeles, CA.

Dr. Athanasiou has no financial relationships with companies related to this material.

Substance-induced psychosis (SIP) presents diagnostic challenges in distinguishing it from primary psychotic disorders, with substance timing, symptom type, and duration being key differentiators. Effective treatment combines antipsychotic medications and substance cessation strategies. Dr. Athanasiou reviews key points in the management of SIP.


Read More
Expert Q&A

Tolerability of Vortioxetine for Pediatric Anxiety and Depressive Disorders

January 1, 2024
Kathryn Martin, MD, MPH
From The Carlat Child Psychiatry Report
Issue Links: Editorial Information | PDF of Issue

Kathryn Martin, MD, MPH. Dr. Martin discloses that she owns shares in a variety of pharmaceutical companies. Relevant financial relationships listed for the author have been mitigated.

Vortioxetine has to be reasonably tolerated in children and teens, with manageable side effects, to have any chance of inclusion into treatment for anxiety or depression. This research update gives you the latest on whether vortioxetine might be a viable approach even before we have good efficacy studies. 


Read More
Expert Q&A

Dysmorphology for Child Psychiatrists

January 1, 2024
Marilyn C. Jones, MD
From The Carlat Child Psychiatry Report
Issue Links: Editorial Information | PDF of Issue

QA2_Marilyn Jones_photo.jpegMarilyn C. Jones, MD

Clinical Service Chief, Genetics, Rady Children’s Hospital-San Diego; Distinguished Professor of Clinical Pediatrics, UCSD, San Diego, CA.

Dr. Jones has no financial relationships with companies related to this material.

You probably studied genetic conditions during your training, however, it is easy to miss some of these kids and teens in your clinical practice. Our interview with Dr. Marilyn Jones will help you learn what the more common conditions are, how spot them, and what to do next. 


Read More
Expert Q&A

Don’t Forget Fetal Alcohol Spectrum Disorders

January 1, 2024
Ira J. Chasnoff, MD
From The Carlat Child Psychiatry Report
Issue Links: Editorial Information | PDF of Issue

QA1_Headshot_Ira Chasnoff_photo.jpgIra J. Chasnoff, MD.

Professor of Clinical Pediatrics, University of Illinois College of Medicine, Chicago, IL; President, NTI Upstream, Chicago, IL.

Dr. Chasnoff’s company, NTI Upstream, receives a licensing fee for the 4Ps Plus© screening instrument. Relevant financial relationships listed for the author have been mitigated.

What do you look for to diagnose Fetal Alcohol Spectrum Disorder (FASD)? Read this interview with Dr. Ira Chasnoff to understand the broad impact of FASD and what to look for in the patient’s history (hint: you usually won’t see facial stigmata).


Read More
Expert Q&A

Decoding Drug Promotion Tactics in Geriatric Psychiatry

January 1, 2024
David Healy, MD, FRCPsych
From The Carlat Geriatric Psychiatry Report
Issue Links: Editorial Information | PDF of Issue

QA2_David Healy_photo.JPGDavid Healy, MD, FRCPsych. Chief Scientific Officer, Data Based Medicine Ltd, Bangor, Wales, UK.

Dr. Healy has no financial relationships with companies related to this material.

From our evidence base to continuing medical education, Dr. David Healy reveals the vast influence of pharmaceutical marketing and offers tips on how to minimize bias.


Read More
CGPR_shutterstock_1433830391.png
Expert Q&A

Cannabis Use for Managing Agitation in Dementia

January 1, 2024
Aaron Greenstein, MD.
From The Carlat Geriatric Psychiatry Report
Issue Links: Editorial Information | PDF of Issue

QA1_Aaron Greenstein_Headshot.jpgAaron Greenstein, MD.

Geriatric psychiatrist in private practice, Denver, CO. Dr. Greenstein is a medical advisor for BrainCheck, Sensi.AI, and Optimize VBC. He is a consultant for GE Healthcare and LEK Consulting.

Relevant financial relationships listed for the author have been mitigated.

Dr. Aaron Greenstein describes when to use dronabinol and dispensary cannabis products for treating agitation in dementia.


Read More
QA photo_T Schwartz_.jpg
Expert Q&A

How to Choose an Antidepressant

January 1, 2024
Thomas Schwartz, MD
From The Carlat Psychiatry Report
Issue Links: Editorial Information | PDF of Issue

QA photo_T Schwartz_.jpgThomas Schwartz, MD.

Professor and Chair, Department of Psychiatry and Behavioral Sciences, Alan and Marlene Norton College of Medicine, SUNY Upstate Medical University, Syracuse, NY.

Dr. Schwartz has no financial relationships with companies related to this material.

Thomas Schwartz clarifies how to choose an antidepressant and finds a place for underutilized agents like trazodone and levomilnacipran (Fetzima).


Read More
Previous 1 2 3 4 5 6 7 8 9 … 14 15 Next
Carlat Total Access Subscriptions: Get access to every article on the website.

Complete access to every article you search on the website.

Shop for Total Access
Free Psychiatry Updates
The latest unbiased psychiatric information sent to your inbox.
Specify Your Interests
Featured Book
  • HospPsychiatry_Spiral_Binding_Sm.png

    Hospital Psychiatry Fact Book, First Edition (2025) - Spiral Bound

    This comprehensive guide is designed to be a valuable resource for professionals working in...
    READ MORE
Featured Video
  • KarXT (Cobenfy)_ The Breakthrough Antipsychotic That Could Change Everything.jpg
    General Psychiatry

    KarXT (Cobenfy): The Breakthrough Antipsychotic That Could Change Everything

    Read More
Featured Podcast
  • shutterstock_2635946985.jpg
    General Psychiatry

    AI in Practice

    Listen now
Recommended
  • Join Our Writing Team

    July 18, 2024
    WriteForUs.png
  • Insights About a Rare Transmissible Form of Alzheimer's Disease

    February 9, 2024
    shutterstock_2417738561_PeopleImages.com_Yuri A.png
  • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

    May 24, 2024
    DEA_Checkbox.png
  • Join Our Writing Team

    July 18, 2024
    WriteForUs.png
  • Insights About a Rare Transmissible Form of Alzheimer's Disease

    February 9, 2024
    shutterstock_2417738561_PeopleImages.com_Yuri A.png
  • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

    May 24, 2024
    DEA_Checkbox.png
  • Join Our Writing Team

    July 18, 2024
    WriteForUs.png
  • Insights About a Rare Transmissible Form of Alzheimer's Disease

    February 9, 2024
    shutterstock_2417738561_PeopleImages.com_Yuri A.png
  • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

    May 24, 2024
    DEA_Checkbox.png

About

  • About Us
  • CME Center
  • FAQ
  • Contact Us

Shop Online

  • Newsletters
  • Multimedia Subscriptions
  • Books
  • eBooks
  • ABPN Self-Assessment Courses

Newsletters

  • The Carlat Psychiatry Report
  • The Carlat Child Psychiatry Report
  • The Carlat Addiction Treatment Report
  • The Carlat Hospital Psychiatry Report
  • The Carlat Geriatric Psychiatry Report
  • The Carlat Psychotherapy Report

Contact

carlat@thecarlatreport.com

866-348-9279

PO Box 626, Newburyport MA 01950

Follow Us

Please see our Terms and Conditions, Privacy Policy, Subscription Agreement, Use of Cookies, and Hardware/Software Requirements to view our website.

© 2025 Carlat Publishing, LLC and Affiliates, All Rights Reserved.